Download presentation
Presentation is loading. Please wait.
Published byAubrey Daniel Modified over 8 years ago
1
PMTCT around the world Where are we? PMTCT Experts Roundtable Geneva, 23-34 June 2008
2
WHO protocol: women in need of ART treat For the newborn AZT for 1 or 4 weeks (depending on the time on ART of the mother)
3
Women not needing ART
4
Infant feeding When replacement feeding is acceptable, feasible, affordable, sustainable and safe (AFASS), avoidance of all breastfeeding by HIV+ mother is recommended. Exclusive breastfeeding is recommended for HIV+ women for the first 6 months unless replacement feeding is AFASS for them and their infant. Continue beyond 6 months (add complementary food) if RF still not AFASS
5
US Guidelines Ante-partum HAART (avoid EFV, TDF, NFV, d4T+ddI) started after 1 st trimester (before if for her own health). Elective C/S for women with HIV RNA >1,000 IV AZT during delivery Avoidance of breastfeeding AZT 6 weeks for the newborn
6
IMPLEMENTATION From Toward Universal Access Progress Report 2008
7
HIV testing and Counselling 18% of pregnant women received an HIV test18% of the total estimated number of pregnant women in low- and middle-income countries (20.6 million of 115 million pregnant women) received an HIV test in 2007 (from 16% in 2006 and 10% in 2004) Testing coverage varies between 4% in Nigeria and 65% in Zambia Antenatal care is relatively high in most of low- and middle income countries (75%) but PICT is still not implemented
8
Antiretrovirals for PMTCT 33% of HIV+ pregnant women received ARV for PMTCT33% of HIV+ pregnant women received ARV for PMTCT (491.000/1.5 mil). From 23% in 2006 and 10% in 2004. Some dramatic success in reducing transmission: –From 30.5% to 11.4% (2001-2007) in Cambodia –From 30.5% to 8.9% (2001-2007) in Rwanda
9
Coverage for ARV in PMTCT - 2007
10
Big differences among countries
11
Coverage of infant prophylaxis 20% by the end of 200720% by the end of 2007 (7% in 2004, 18% in 2006) Widening gap between coverage of antiretroviral for mothers and for infants
12
Antiretroviral regimens used for PMTCT - 2007 60 countries provided disaggregated data (accounting for 60% of the total estimated HIV+ pregnant women): –49% of women received single dose NVP –26% received a combination of 2 ARV –8% receiving a combination of three ARV –Only 7% received ARV for their own health in SSA
13
Availability of CD4 testing in ANC 2007
14
Infant feeding Difficult to have reliable data Exclusive breastfeeding worldwide (< 6 months) increased of 5-6 percentage points in the last 15 years (!) 39% in 2005 (?)
15
Infant management Only 8% were tested within 2 months of birth.Only 8% of the 715.000 children born to HIV+ women in 2007 were tested within 2 months of birth (data from 77 (71%) countries). Only 4% received CTX prophylaxisOnly 4% of exposed children (1.5 Millions) received CTX prophylaxis within 2 months of birth
16
Conclusions Big differences in the recommended protocol between countries Implementation of PMTCT program in low and middle income countries: –Low coverage of testing in ANC, but improving –Sd NVP still widely used –ANC/PMTCT not used as entry point for access to treatment
Similar presentations
© 2024 SlidePlayer.com. Inc.
All rights reserved.